Skip to main content
SpringerLink
Log in

The History of Inpatient Diabetes

  • Chapter
  • First Online:
Diabetes Management in Hospitalized Patients

Part of the book series: Contemporary Endocrinology ((COE))

Abstract

Following the discovery of insulin in 1921 by Frederick Banting and Charles Best, the approach to inpatient diabetes care has evolved over time to optimize patient outcomes. Newer insulin formulations, modernized tools to quantify glycemia, advanced diabetes technologies, and research trials supporting a shift in clinical practice have marked important milestones throughout the history of diabetes. Despite the strong evidence in support of improved glycemic control in hospitalized patients, however, blood glucose control continues to be deficient and is often overlooked in general medicine and surgery services. This chapter provides insight into inpatient diabetes epidemiology, reviews the pivotal studies of inpatient diabetes management, outlines the history of major diabetes guidelines, describes specialized hospital-based diabetes teams, and summarizes the history and future of diabetes technology.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Banting FG, Campbell WR, Fletcher AA. Further clinical experience with insulin (pancreatic extracts) in the treatment of diabetes mellitus. Br Med J. 1923;1(3236):8–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Migdal AL, Idrees T, Umpierrez GE. Selecting insulin regimens for the management of non-ICU patients with type 2 diabetes. J Endocr Soc. 2021;5(10):bvab134.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Vecchio I, Tornali C, Bragazzi NL, Martini M. The discovery of insulin: an important milestone in the history of medicine. Front Endocrinol (Lausanne). 2018;9:613.

    Article  PubMed  Google Scholar 

  4. Centers for Disease Control and Prevention. 2022. https://www.cdc.gov/diabetes/data/statistics-report.

  5. Zhang Y, Bullard KM, Imperatore G, Holliday CS, Benoit SR. Proportions and trends of adult hospitalizations with diabetes, United States, 2000–2018. Diabetes Res Clin Pract. 2022;187:109862.

    Article  CAS  PubMed  Google Scholar 

  6. American Diabetes Association. Economic costs of diabetes in the U.S. in 2017. Diabetes Care. 2018;41(5):917–28.

    Article  PubMed Central  Google Scholar 

  7. Carpenter DL, Gregg SR, Xu K, Buchman TG, Coopersmith CM. Prevalence and impact of unknown diabetes in the ICU. Crit Care Med. 2015;43(12):e541–50.

    Article  CAS  PubMed  Google Scholar 

  8. Benoit SR, Zhang Y, Geiss LS, Gregg EW, Albright A. Trends in diabetic ketoacidosis hospitalizations and in-hospital mortality-United States, 2000–2014. MMWR Morb Mortal Wkly Rep. 2018;67(12):362–5.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Updated December 29, 2021. https://www.cdc.gov/diabetes/data/statistics-report/coexisting-conditions-complications.html. Accessed 13 Sept 2022.

  10. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978–82.

    Article  CAS  PubMed  Google Scholar 

  11. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355(9206):773–8.

    Article  CAS  PubMed  Google Scholar 

  12. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32(10):2426–32.

    Article  CAS  PubMed  Google Scholar 

  13. Klonoff DC, Messler JC, Umpierrez GE, Peng L, Booth R, Crowe J, et al. Association between achieving inpatient glycemic control and clinical outcomes in hospitalized patients with COVID-19: a multicenter, retrospective hospital-based analysis. Diabetes Care. 2021;44(2):578–85.

    Article  CAS  PubMed  Google Scholar 

  14. Investigators N-SS, Finfer S, Chittock DR, Su SY, Blair D, Foster D, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–97.

    Article  Google Scholar 

  15. Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007;30(9):2181–6.

    Article  CAS  PubMed  Google Scholar 

  16. Alberti KG, Hockaday TD, Turner RC. Small doses of intramuscular insulin in the treatment of diabetic “coma”. Lancet. 1973;2(7828):515–22.

    Article  CAS  PubMed  Google Scholar 

  17. Kitabchi AE, Ayyagari V, Guerra SM. The efficacy of low-dose versus conventional therapy of insulin for treatment of diabetic ketoacidosis. Ann Intern Med. 1976;84(6):633–8.

    Article  CAS  PubMed  Google Scholar 

  18. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26(1):57–65.

    Article  CAS  PubMed  Google Scholar 

  19. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359–67.

    Article  PubMed  Google Scholar 

  20. Umpierrez GE, Latif K, Stoever J, Cuervo R, Park L, Freire AX, et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med. 2004;117(5):291–6.

    Article  CAS  PubMed  Google Scholar 

  21. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract. 2004;10(Suppl 2):21–33.

    Article  PubMed  Google Scholar 

  22. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449–61.

    Article  PubMed  Google Scholar 

  23. Umpierrez G, Cardona S, Pasquel F, Jacobs S, Peng L, Unigwe M, et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary artery bypass graft surgery: GLUCO-CABG trial. Diabetes Care. 2015;38(9):1665–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Umpierrez GE, Smiley D, Jacobs S, Peng L, Temponi A, Mulligan P, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011;34(2):256–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Umpierrez GE, Smiley D, Hermayer K, Khan A, Olson DE, Newton C, et al. Randomized study comparing a basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care. 2013;36(8):2169–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Migdal AL, Fortin-Leung C, Pasquel F, Wang H, Peng L, Umpierrez GE. Inpatient glycemic control with sliding scale insulin in noncritical patients with type 2 diabetes: who can slide? J Hosp Med. 2021;16(8):462–8.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Black AB, Malins JM. Diabetic ketosis; a comparison of results of orthodox and intensive methods of treatment based on 170 consecutive cases. Lancet. 1949;1(6541):56–9.

    Article  CAS  PubMed  Google Scholar 

  28. Kitabchi AE, Umpierrez GE, Fisher JN, Murphy MB, Stentz FB. Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Endocrinol Metab. 2008;93(5):1541–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Pasquel FJ, Umpierrez GE. Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment. Diabetes Care. 2014;37(11):3124–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Smith K, Martin HE. Response of diabetic coma to various insulin dosages. Diabetes. 1954;3(4):287–94.

    Article  CAS  PubMed  Google Scholar 

  31. Andrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, Gonzalez-Padilla DA. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis. Cochrane Database Syst Rev. 2016;2016(1):CD011281.

    PubMed  PubMed Central  Google Scholar 

  32. Inpatient Insulin Protocols-COVID-19. 2022. https://professional.diabetes.org/content-page/inpatient-insulin-protocols-covid-19.

  33. American Diabetes Association Professional Practice Committee, Draznin B, Aroda VR, Bakris G, Benson G, et al. 16. Diabetes care in the hospital: standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S244–S53.

    Article  Google Scholar 

  34. Blonde L, Umpierrez GE, Reddy SS, McGill JB, Berga SL, Bush M, et al. American Association of Clinical Endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan-2022 update. Endocr Pract. 2022;28(10):923–1049.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16–38.

    Article  CAS  PubMed  Google Scholar 

  36. Korytkowski MT, Muniyappa R, Antinori-Lent K, Donihi AC, Drincic AT, Hirsch IB, et al. Management of hyperglycemia in hospitalized adult patients in non-critical care settings: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2022;107(8):2101–28.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Striker C. The early history of the American Diabetes Association. Diabetes. 1956;5(4):317–20.

    Article  CAS  PubMed  Google Scholar 

  38. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 1989;12(5):365–8.

    Article  Google Scholar 

  39. How AACE Got Started 2022. https://pro.aace.com/about/how-aace-got-started.

  40. Lebovitz HE, Austin MM, Blonde L, Davidson JA, Del Prato S, Gavin JR 3rd, et al. ACE/AACE consensus conference on the implementation of outpatient management of diabetes mellitus: consensus conference recommendations. Endocr Pract. 2006;12(Suppl 1):6–12.

    Article  PubMed  Google Scholar 

  41. Levetan CS, Salas JR, Wilets IF, Zumoff B. Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. Am J Med. 1995;99(1):22–8.

    Article  CAS  PubMed  Google Scholar 

  42. Koproski J, Pretto Z, Poretsky L. Effects of an intervention by a diabetes team in hospitalized patients with diabetes. Diabetes Care. 1997;20(10):1553–5.

    Article  CAS  PubMed  Google Scholar 

  43. Haque WZ, Demidowich AP, Sidhaye A, Golden SH, Zilbermint M. The financial impact of an inpatient diabetes management service. Curr Diabetes Rep. 2021;21(2):5.

    Article  Google Scholar 

  44. Zhu Y, Yang Y, Yang M, Xia W, Zhou H, Zhu XJ, et al. Effect of informatization-based blood glucose team management on the control of hyperglycaemia in noncritical care units. PLoS One. 2020;15(3):e0230115.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Newton CA, Young S. Financial implications of glycemic control: results of an inpatient diabetes management program. Endocr Pract. 2006;12(Suppl 3):43–8.

    Article  PubMed  Google Scholar 

  46. Flanagan D, Moore E, Baker S, Wright D, Lynch P. Diabetes care in hospital—the impact of a dedicated inpatient care team. Diabetes Med. 2008;25(2):147–51.

    Article  CAS  Google Scholar 

  47. Mandel SR, Langan S, Mathioudakis NN, Sidhaye AR, Bashura H, Bie JY, et al. Retrospective study of inpatient diabetes management service, length of stay and 30-day readmission rate of patients with diabetes at a community hospital. J Community Hosp Intern Med Perspect. 2019;9(2):64–73.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Bansal V, Mottalib A, Pawar TK, Abbasakoor N, Chuang E, Chaudhry A, et al. Inpatient diabetes management by specialized diabetes team versus primary service team in non-critical care units: impact on 30-day readmission rate and hospital cost. BMJ Open Diabetes Res Care. 2018;6(1):e000460.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Moodley N, Ngxamngxa U, Turzyniecka MJ, Pillay TS. Historical perspectives in clinical pathology: a history of glucose measurement. J Clin Pathol. 2015;68(4):258–64.

    Article  CAS  PubMed  Google Scholar 

  50. Clarke SF, Foster JR. A history of blood glucose meters and their role in self-monitoring of diabetes mellitus. Br J Biomed Sci. 2012;69(2):83–93.

    Article  CAS  PubMed  Google Scholar 

  51. Umpierrez GE, Klonoff DC. Diabetes technology update: use of insulin pumps and continuous glucose monitoring in the hospital. Diabetes Care. 2018;41(8):1579–89.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Pickup JC, Keen H, Parsons JA, Alberti KG. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. Br Med J. 1978;1(6107):204–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Tamborlane WV, Sherwin RS, Genel M, Felig P. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med. 1979;300(11):573–8.

    Article  CAS  PubMed  Google Scholar 

  54. Kesavadev J, Saboo B, Krishna MB, Krishnan G. Evolution of insulin delivery devices: from syringes, pens, and pumps to DIY artificial pancreas. Diabetes Ther. 2020;11(6):1251–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Misso ML, Egberts KJ, Page M, O'Connor D, Shaw J. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2010;2016(1):CD005103.

    Google Scholar 

  56. Beato-Vibora P, Yeoh E, Rogers H, Hopkins D, Amiel SA, Choudhary P. Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with type 1 diabetes. Diabet Med. 2015;32(11):1453–9.

    Article  CAS  PubMed  Google Scholar 

  57. Davis GM, Galindo RJ, Migdal AL, Umpierrez GE. Diabetes technology in the inpatient setting for management of hyperglycemia. Endocrinol Metab Clin N Am. 2020;49(1):79–93.

    Article  Google Scholar 

  58. American Diabetes Association. 7. diabetes technology: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S85–99.

    Article  Google Scholar 

  59. Cook CB, Beer KA, Seifert KM, Boyle ME, Mackey PA, Castro JC. Transitioning insulin pump therapy from the outpatient to the inpatient setting: a review of 6 years’ experience with 253 cases. J Diabetes Sci Technol. 2012;6(5):995–1002.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Galindo RJ, Aleppo G, Klonoff DC, Spanakis EK, Agarwal S, Vellanki P, et al. Implementation of continuous glucose monitoring in the hospital: emergent considerations for remote glucose monitoring during the COVID-19 pandemic. J Diabetes Sci Technol. 2020;14(4):822–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Agarwal S, Mathew J, Davis GM, Shephardson A, Levine A, Louard R, et al. continuous glucose monitoring in the intensive care unit during the COVID-19 pandemic. Diabetes Care. 2021;44(3):847–9.

    Article  CAS  PubMed  Google Scholar 

  62. Davis GM, Spanakis EK, Migdal AL, Singh LG, Albury B, Urrutia MA, et al. Accuracy of Dexcom G6 continuous glucose monitoring in non-critically ill hospitalized patients with diabetes. Diabetes Care. 2021;44(7):1641–6.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Spanakis EK, Urrutia A, Galindo RJ, Vellanki P, Migdal AL, Davis G, et al. Continuous glucose monitoring-guided insulin administration in hospitalized patients with diabetes: a randomized clinical trial. Diabetes Care. 2022;45(10):2369–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Galindo RJ, Migdal AL, Davis GM, Urrutia MA, Albury B, Zambrano C, et al. Comparison of the FreeStyle Libre Pro flash continuous glucose monitoring (CGM) system and point-of-care capillary glucose testing in hospitalized patients with type 2 diabetes treated with basal-bolus insulin regimen. Diabetes Care. 2020;43(11):2730–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Chee F, Fernando T, van Heerden PV. Closed-loop glucose control in critically ill patients using continuous glucose monitoring system (CGMS) in real time. IEEE Trans Inf Technol Biomed. 2003;7(1):43–53.

    Article  PubMed  Google Scholar 

  66. Leelarathna L, English SW, Thabit H, Caldwell K, Allen JM, Kumareswaran K, et al. Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial. Crit Care. 2013;17(4):R159.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Yatabe T, Yamazaki R, Kitagawa H, Okabayashi T, Yamashita K, Hanazaki K, et al. The evaluation of the ability of closed-loop glycemic control device to maintain the blood glucose concentration in intensive care unit patients. Crit Care Med. 2011;39(3):575–8.

    Article  CAS  PubMed  Google Scholar 

  68. Thabit H, Hartnell S, Allen JM, Lake A, Wilinska ME, Ruan Y, et al. Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial. Lancet Diabetes Endocrinol. 2017;5(2):117–24.

    Article  CAS  PubMed  Google Scholar 

  69. Bally L, Thabit H, Hartnell S, Andereggen E, Ruan Y, Wilinska ME, et al. Closed-loop insulin delivery for glycemic control in noncritical care. N Engl J Med. 2018;379(6):547–56.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

DB and RSR have nothing to disclose for this chapter.

RJG is supported in part by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) under award numbers P30DK111024-04S2 and 1K23DK123384-03. RJG received unrestricted research support (to Emory University) from Novo Nordisk, Eli Lilly, and Dexcom and consulting fees from Sanofi, Novo Nordisk, Eli Lilly, Pfizer, Boehringer, Bayer, and Weight Watchers.

GEU is partly supported by research grants from the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR002378 and from the National Institutes of Health and National Center for Research Resources (NIH/NIDDK 2P30DK111024-06). GEU has received research support (to Emory University) from Bayer, Abbott, Sanofi, and Dexcom.

Author information

Authors and Affiliations

  1. Division of Endocrinology, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, New York, NY, USA

    Danielle Brooks & Rifka C. Schulman-Rosenbaum

  2. Division of Endocrinology, Department of Medicine, University of Miami Miller School of Medicine, Lennar Medical Center, University of Miami Health System, Jackson Memorial Health System, Miami, FL, USA

    Rodolfo Galindo

  3. Division of Endocrinology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA

    Guillermo E. Umpierrez

Authors
  1. Danielle Brooks
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rifka C. Schulman-Rosenbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rodolfo Galindo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Guillermo E. Umpierrez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Danielle Brooks .

Editor information

Editors and Affiliations

  1. Division of Endocrinology, Long Island Jewish Medical Center, Northwell Health, New Hyde Park, NY, USA

    Rifka C. Schulman-Rosenbaum

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Brooks, D., Schulman-Rosenbaum, R.C., Galindo, R., Umpierrez, G.E. (2023). The History of Inpatient Diabetes. In: Schulman-Rosenbaum, R.C. (eds) Diabetes Management in Hospitalized Patients. Contemporary Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-031-44648-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-44648-1_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-44647-4

  • Online ISBN: 978-3-031-44648-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation